> > > >
Contact:
sales@biotechnologyforums.com to feature here
Thread Rating:
  • 0 Vote(s) - 0 Average
  • 1
  • 2
  • 3
  • 4
  • 5
Latest Developments in Biotechnology Firms this Month | November 2013
Offline
Administrator Offline
Administrator
*******
Posts: 26
Threads: 6
Likes Received: 0 in 0 posts
Likes Given: 0
Joined: Jun 2010
Country: Las Vegas, Nevada
BioEXP: 26.73Bx
#2
11-11-2013, 11:53 PM
UK-listed drug company Shire has agreed to buy the US's ViroPharma - a rare disease biopharmaceutical firm - for about $4.2bn (£2.6bn).

Shire will pay $50 for each ViroPharma share - a 27% premium on Friday's closing price.
Find Share
Like Post Reply
  


Messages In This Thread
Shire buys US drug firm ViroPharma for $4.2bn - by Administrator - 11-11-2013, 11:53 PM
Possibly Related Threads…
Thread
Author
  /  
Last Post
The Best Biotechnology Product 2013 – Zostavax
priyasaravanan_1406
Replies: 3
Views: 23,497
01-06-2017, 05:59 AM
Last Post: Brii1920
Biotechnology winners in the 2013 Presidential Green Chemistry Challenge Awards
mtwalsh01
Replies: 0
Views: 8,905
12-18-2013, 11:53 PM
Last Post: mtwalsh01
2013 Malaria Vaccine Technology Roadmap
mtwalsh01
Replies: 0
Views: 9,730
11-20-2013, 08:34 AM
Last Post: mtwalsh01
Biotechnology and batteries: modified viruses build electrodes
mtwalsh01
Replies: 0
Views: 9,278
11-20-2013, 03:05 AM
Last Post: mtwalsh01



Users browsing this thread:
1 Guest(s)

Latest Developments in Biotechnology Firms this Month | November 201300